Study of the protective mechanisms of Compound Danshen Tablet (Fufang Danshen Pian) against myocardial ischemia/reperfusion injury via the Akt-eNOS signaling pathway in rats

Abstract

Ethnopharmacological relevanceCompound Danshen Tablet (CDT), an herbal preparation consisting of Salvia miltiorrhiza (Radix and rhizome of Salvia miltiorrhiza Bge.), Notoginseng (Radix and rhizome of Panax notoginseng (Burk.) F. H. Chen) and Borneolum Syntheticum, is widely used to improve coronary heart disease, cardiac angina and atherosclerosis in clinic in Asia and Pacific Ocean area, especially in China. AimThe study is to research the protective mechanisms of Compound Danshen Tablet (CDT) against myocardial ischemia/reperfusion (MI/R) injury via the Akt-eNOS signaling Pathway in rats. Materials and methodsRats were randomized into 7 groups: Sham group; Model group; Low-Dose CDT group (0.315g/kg/d, i.g); Middle-Dose CDT group (0.63g/kg/d, i.g); High-Dose CDT group (1.26g/kg/d, i.g); Compound Danshen Dripping Pills (CDDP) group (0.0945g/kg/d, i.g); Sulfotanshinone Sodium Injection (Tan II A) group (5mg/kg/d, i.m). After the administration, the hearts of the rats were subjected to 30min of coronary artery occlusion and 2h of reperfusion except the Sham group rats. ResultsCDT significantly decreased infarct size, apoptosis, caspase-3 protein expression, MDA level in myocardial tissues, the activities of serum CK, LDH and cTnI; on the contrary, it increased p-Akt, p-eNOS, bcl-2 protein expression, the activities of SOD and tissue LDH, and the level of NO. ConclusionsCDT can protect cardiomyocytes against MI/R injury and inhibits apoptosis in rats by activating Akt-eNOS signaling pathway.